These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9387952)

  • 1. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease.
    Jankelson D; Hosseini K; Mather LE; Seale JP; Young IH
    Eur Respir J; 1997 Oct; 10(10):2270-4. PubMed ID: 9387952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.
    Young IH; Daviskas E; Keena VA
    Thorax; 1989 May; 44(5):387-90. PubMed ID: 2669222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient.
    Beauford W; Saylor TT; Stansbury DW; Avalos K; Light RW
    Chest; 1993 Jul; 104(1):175-8. PubMed ID: 8325064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
    Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
    Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized morphine: one intervention for end-stage chronic obstructive pulmonary disease (COPD).
    Lord E
    AARN News Lett; 1997 Nov; 53(10):10-1. PubMed ID: 9444084
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.
    Leung R; Hill P; Burdon J
    Thorax; 1996 Jun; 51(6):596-600. PubMed ID: 8693440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease.
    Masood AR; Reed JW; Thomas SH
    Thorax; 1995 Jun; 50(6):629-34. PubMed ID: 7638804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.
    Janowiak P; Krajnik M; Podolec Z; Bandurski T; Damps-Konstańska I; Sobański P; Currow DC; Jassem E
    BMC Pulm Med; 2017 Dec; 17(1):186. PubMed ID: 29228935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
    Cohen SP; Dawson TC
    Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose nebulized morphine does not improve exercise in interstitial lung disease.
    Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1940-5. PubMed ID: 8520759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
    Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nebulized fenoterol on spirometry, dyspnea sensation changes during exercise in patients with chronic obstructive pulmonary disease.
    Chiang LL; Yu CT; Kuo HP
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):129-34. PubMed ID: 8828254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
    Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
    J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man.
    Masood AR; Subhan MM; Reed JW; Thomas SH
    Clin Sci (Lond); 1995 Apr; 88(4):447-52. PubMed ID: 7789047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized morphine for relief of dyspnea due to chronic lung disease.
    Brown SJ; Eichner SF; Jones JR
    Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised morphine for severe interstitial lung disease.
    Polosa R; Simidchiev A; Walters EH
    Cochrane Database Syst Rev; 2002; 2002(3):CD002872. PubMed ID: 12137662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.